Abiopharma

🔍 Dragovich Darren (Executive)

Company: CPI Card Group Inc. (PMTS)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 433 shares of Common Stock (Direct)
  Date: 2026-03-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 3,244.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 125 shares of Common Stock at $14.51 per share (Direct)
  Date: 2026-03-31 | Code: F | equity_swap_involved: 0 | shares_owned_after: 3,119.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 2,594 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 2,594.00 | transaction_form_type: 4 | Footnotes: F1, F3, F3
• Acquired 9,527 shares of Phantom Stock (Derivative)
  Date: 2026-03-31 | Code: A | Expires: 2028-12-31 | Exercise: 2028-12-31 | equity_swap_involved: 0 | shares_owned_after: 9,527.00 | transaction_form_type: 4 | Footnotes: F4
• Sold 433 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 860.00 | transaction_form_type: 4 | Footnotes: F1, F5, F5

Footnotes:

• F1: Each restricted stock unit ("RSU") represents the right to receive one common share of the Issuer upon vesting of such RSU.
• F2: Shares withheld by Issuer to satisfy the mandatory tax withholding requirement upon vesting of RSUs. Not an open market sale of securities.
• F3: Represents a restricted stock unit award which vests in three substantially equal installments on March 31, 2027, 2028, and 2029, subject to the reporting person's continued service through such date or as otherwise provided for in the applicable award agreement.
• F4: Each share of phantom stock is the economic equivalent of one share of the Issuer's common stock. The award is scheduled to vest shortly following the Expiration Date and settle in cash based on a combination of the average closing price of the Issuer's common stock during the last month of the performance period and the achievement of certain performance metrics during the performance period, subject to the reporting person's continuous service through the vesting date or as otherwise provided for in the applicable award agreement.
• F5: This line reports RSUs that were awarded on the March 31, 2025 award date, which vested on the first anniversary of the award date. The remaining RSUs granted on the award date will vest in substantially equal installments on the second and third anniversaries of the award date, subject to the reporting person's continued service through such date or as otherwise provided for in the applicable award agreement.
• REMARKS: Exhibit List: Exhibit 24 - Power of Attorney